225 related articles for article (PubMed ID: 21912701)
1. MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.
Boguslawska J; Wojcicka A; Piekielko-Witkowska A; Master A; Nauman A
PLoS One; 2011; 6(9):e24541. PubMed ID: 21912701
[TBL] [Abstract][Full Text] [Related]
2. Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.
Master A; Wójcicka A; Piekiełko-Witkowska A; Bogusławska J; Popławski P; Tański Z; Darras VM; Williams GR; Nauman A
Biochim Biophys Acta; 2010 Nov; 1802(11):995-1005. PubMed ID: 20691260
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of thyroid hormone receptor beta in renal cancer.
Wojcicka A; Piekielko-Witkowska A; Kedzierska H; Rybicka B; Poplawski P; Boguslawska J; Master A; Nauman A
PLoS One; 2014; 9(5):e97624. PubMed ID: 24849932
[TBL] [Abstract][Full Text] [Related]
4. Regulatory feedback loop between T3 and microRNAs in renal cancer.
Boguslawska J; Piekielko-Witkowska A; Wojcicka A; Kedzierska H; Poplawski P; Nauman A
Mol Cell Endocrinol; 2014 Mar; 384(1-2):61-70. PubMed ID: 24440748
[TBL] [Abstract][Full Text] [Related]
5. Rno-miR-224-5p contributes to 2,2',4,4'-tetrabromodiphenyl ether-induced low triiodothyronine in rats by targeting deiodinases.
Wang C; Zhu J; Zhang Z; Chen H; Ji M; Chen C; Hu Y; Yu Y; Xia R; Shen J; Gong X; Wang SL
Chemosphere; 2020 May; 246():125774. PubMed ID: 31901531
[TBL] [Abstract][Full Text] [Related]
6. Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer.
Piekielko-Witkowska A; Master A; Wojcicka A; Boguslawska J; Brozda I; Tanski Z; Nauman A
Thyroid; 2009 Oct; 19(10):1105-13. PubMed ID: 19534619
[TBL] [Abstract][Full Text] [Related]
7. Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.
Popławski P; Wiśniewski JR; Rijntjes E; Richards K; Rybicka B; Köhrle J; Piekiełko-Witkowska A
PLoS One; 2017; 12(12):e0190179. PubMed ID: 29272308
[TBL] [Abstract][Full Text] [Related]
8. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.
Liang J; Zhang Y; Jiang G; Liu Z; Xiang W; Chen X; Chen Z; Zhao J
Oncol Res; 2013; 21(2):83-91. PubMed ID: 24406044
[TBL] [Abstract][Full Text] [Related]
9. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
11. Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma.
Ueno K; Hirata H; Shahryari V; Chen Y; Zaman MS; Singh K; Tabatabai ZL; Hinoda Y; Dahiya R
Br J Cancer; 2011 Jan; 104(2):308-15. PubMed ID: 21119662
[TBL] [Abstract][Full Text] [Related]
12. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
[TBL] [Abstract][Full Text] [Related]
13. miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma.
Wang X; Chen X; Han W; Ruan A; Chen L; Wang R; Xu Z; Xiao P; Lu X; Zhao Y; Zhou J; Chen S; Du Q; Yang H; Zhang X
Mol Cancer Res; 2015 Dec; 13(12):1567-77. PubMed ID: 26248649
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
[TBL] [Abstract][Full Text] [Related]
15. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
[TBL] [Abstract][Full Text] [Related]
16. miR-106b fine tunes ATG16L1 expression and autophagic activity in intestinal epithelial HCT116 cells.
Zhai Z; Wu F; Chuang AY; Kwon JH
Inflamm Bowel Dis; 2013 Oct; 19(11):2295-301. PubMed ID: 23899543
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.
Niu S; Ma X; Zhang Y; Liu YN; Chen X; Gong H; Yao Y; Liu K; Zhang X
PLoS One; 2018; 13(2):e0192790. PubMed ID: 29474434
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
[TBL] [Abstract][Full Text] [Related]
20. The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.
Chaudhuri E; Dash S; Balasubramaniam M; Padron A; Holland J; Sowd GA; Villalta F; Engelman AN; Pandhare J; Dash C
J Biol Chem; 2020 Apr; 295(15):5081-5094. PubMed ID: 32152226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
